Aflibercept in refractory wet AMD treated with ranibizumab: Anatomical and visual outcome

PURPOSE: To assess the anatomical outcome of patients with exudative age-related macular degeneration resistant to ranibizumab treated with aflibercept. METHOD: Prospective, interventional, case series, where we treated a group of patients deemed resistant to Ranibizumab after 6 months of persistenc...

Descripción completa

Detalles Bibliográficos
Autor principal: Abou-Ltaif, Sleiman
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2016
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5161818/
https://www.ncbi.nlm.nih.gov/pubmed/28003780
http://dx.doi.org/10.1016/j.sjopt.2016.10.008

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5161818/
https://www.ncbi.nlm.nih.gov/pubmed/28003780
http://dx.doi.org/10.1016/j.sjopt.2016.10.008

Ejemplares similares